COPD Assessment Test (CAT)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۵

حداقل ۰ — حداکثر ۵

حداقل ۰ — حداکثر ۵

حداقل ۰ — حداکثر ۵

حداقل ۰ — حداکثر ۵

حداقل ۰ — حداکثر ۵

حداقل ۰ — حداکثر ۵

حداقل ۰ — حداکثر ۵

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
cat score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low impact0–10
  • Medium impact11–20
  • High impact21–30
  • Very high impact31–40
Direct Clinical Answer

The COPD Assessment Test (CAT) calculates assessing multiple aspects of COPD including respiratory symptoms, activity limitations, confidence, and sleep quality. Key inputs include cough. Scores guide determining appropriate admission level (floor versus ICU), tailoring antimicrobial therapy, and ventilatory support. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Quantifies the impact of COPD symptoms on patients' overall health and quality of life. The CAT is a patient-completed questionnaire that assesses multiple aspects of COPD including respiratory symptoms, activity limitations, confidence, and sleep quality.

Clinical Indication

The COPD Assessment Test (CAT) is indicated for bedside clinical practice to support Quantifies the impact of COPD symptoms on patients' overall health and quality of life. The CAT is a patient-completed questionnaire that assesses multiple aspects of COPD including respiratory symptoms, activity limitations, confidence, and sleep quality.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.

Limitations & Contraindications

Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.

Clinical Pearls & Action Plan

Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management. Guideline pearl: Should be repeated every 2-3 months to monitor progression and treatment response.

Formula & Variables:

CAT Score = Sum of all 8 item scores (each scored 0-5)

Input Parameters

NameTypeRequiredDescription
coughintegerYesFrequency of coughing
phlegmintegerYesAmount of phlegm (mucus) in chest
chest_tightnessintegerYesFeeling of chest tightness
breathlessnessintegerYesBreathlessness when walking up a hill or one flight of stairs
activitiesintegerYesLimitation doing activities at home
confidenceintegerYesConfidence leaving home despite lung condition
sleepintegerYesSleep quality affected by lung condition
energyintegerYesEnergy level

Score Interpretation & Guidance

RangeStageDescription
0–10Low impactLow COPD impact on health
11–20Medium impactMedium COPD impact on health
21–30High impactHigh COPD impact on health
31–40Very high impactVery high COPD impact on health

Evidence-Based References (EBM)

  • Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009 Sep;34(3):648-54. doi: 10.1183/09031936.00102509.DOI: 10.1183/09031936.00102509
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: 2023 Report.
  • Gupta N, Pinto LM, Morogan A, Bourbeau J. The COPD assessment test: a systematic review. Eur Respir J. 2014 Oct;44(4):873-84. doi: 10.1183/09031936.00025214.DOI: 10.1183/09031936.00025214

Related calculators